The essential oil of Chrysactinia mexicana retrieved from the root bark was characterized by gas chromatography coupled to a mass detector. The compounds silphiperfol-5-ene, 7-epi-silphiperfol-5-ene, modheph-2-ene, -isocomene, -isocomene and methyl-linoleate were identified. The principal compound (76.42%) could not be identified by the library and was further isolated through a reverse phase C-18 chromatography followed by silica gel chromatography and identified as 5-(3-buten-1-ynyl)-2,2'-bithienyl. Both the oil and the isolated compound were tested for their antimicrobial activity against two strains of Streptococcus pneumoniae resistant to -lactam antibiotics. MICs were 250 g/mL and 125 g/mL respectively. This is the first report about extraction of oil and compound 5-(3-buten-1-ynyl)-2, 2'-bithienyl from roots of Chrysactinia mexicana as well as the determination of antimicrobial activity against S. pneumoniae.
Essential oils are used in alternative medicine as a remedy for many infectious diseases, antimicrobial properties have been long established and several studies have confirmed that they have activity against bacteria, yeasts and fungi [1] [2] [3] . Essential oils have been traditionally used for respiratory tract infections [4] .
Chrysactinia mexicana, is a fragrant plant that contains essential oils in aerial part, commonly known as calanque, damianita, hierba de San Nicolás or falsa damiana. It is distributed throughout northern Mexico and Texas, USA. It use is known for to treat respiratory illnesses and skin infections. The leaves and stems are used as a diuretic, to counteract stomach ailments or postpartum pain, using the root as a home remedy [5] . The activity of an ether extract of the roots of Chrysactinia mexicana against two strains of Streptococcus pneumoniae resistant to penicillin have been reported [6] .
Streptococcus pneumoniae, is a major causative agents of infectious diseases of the respiratory tract, causing a significant number of deaths worldwide, in both hospital and community, affecting mainly children and elderly. This situation is exacerbated by the increasingly frequent emergence of resistant strains. This infectious disease is the leading cause of death in developing countries, followed by heart disease, diarrhea, HIV/AIDS and stroke. Pneumonia is the leading cause of death in children under 5 years and about two million deaths each year among this group of people around the world, mainly in low resource environments, poor nutrition and poor hygiene conditions [7, 8] . In the last decades has increased the incidence of pneumococcal infections in adults, despite the wide availability of effective antibiotics, continue to cause high morbidity and mortality, reporting mortality rates of up to 20% in adult patients with bacterium [9, 10] . Due to the great problem posed by bacterial infections, was reviewed the importance of using traditional medicine, mainly using natural products of plant origin, to counteract these diseases, including respiratory tract infections [11] . Our aim was to obtain the essential oil from the root of Chrysactinia mexicana, characterize their composition, to isolate some key components and evaluate their antimicrobial activity against two strains of Streptococcus pneumoniae resistant to -lactam antibiotics.
Since there are reports of Chrysactinia mexicana use in folk medicine for the treatment of respiratory diseases and scientific studies of activity of both the shoot and root against various microorganisms [5, 6, 12] , our aim in this work was, to characterize their composition, to isolate some key components and to evaluate their antimicrobial activity against two strains of Streptococcus pneumoniae resistant to -lactam antibiotics.
In preliminary experiments we tested the activity of essential oil from the root bark and root without bark of Chrysactinia mexicana against two strains of Streptococcus pneumoniae resistant -lactam antibiotics (ATCC 49619 and 24-CCPN-02) and we found major activity in root bark (MIC of 250 g/mL against both strains), therefore we decided to work specifically with the root bark. We obtained a dark yellow essential oil with yield of 0.41%.
Cárdenas et al. reported the characterization of the essential oil from the leaves of this plant showing that the main components are terpenes, including eucalyptol (41.3%) and piperitone (37.7%) [12] . So far, no studies are available on the characterization of extract components or essential oil from root of Chrysactinia mexicana. This work is the first report on the study of the root of this plant, specifically of the essential oil obtained from the bark. GC/MS analysis showed the presence of 12 compounds. The main component had a retention time of 59.85 minutes and represented the 76.42%, other component with retention time of 66.43 minutes, represented the 8.34%. However, neither could be identified using the NIST library. Only six of the 12 compounds were identified from GC/MS spectra using the NIST library and they represented the 8.50% of total area. Five of them were sesquiterpenes (silphiperfol-5-ene, 7epi-silphiperfol-5-ene, modheph-2-ene, ɑ-isocomene and ß-isocomene) and one was the esther methyl-linoleate. The sesquiterpenes have been reported in roots from Silphium perfoliatum and Echinops giganteus [13, 14] . Other three minor component representing 15.08% of the total area were no identified ( Table 1) . Because the main component could not be identified by NIST library, we decided to isolate it and identified by spectroscopic techniques.
Essential oil obtained from the root bark of Chrysactinia mexicana was further purified by means of reverse phase low-pressure liquid chromatography, to afford the active compound six fractions were obtained (F1 to F6). The most important compound was found in fraction F5 and the yield was 34%. A gravitational column chromatography on silica gel was performed from F5 to give 4 fractions (F5a to F5d) and, pure compound was obtained in F5b representing a yield of 64.4% from the F5 initially placed in this column.
Compound was subjected to structural analysis. CG/MS analysis displayed one peak at 59.85 minutes with m/z 216 (M + ). IR showed several important signals at  max 3000-3104 cm -1 (C-H), 2192.53 cm -1 (triple bound C-C), 1636.14 cm -1 and 1602.86 cm -1 (terminal olefin) and 785 y 838 cm-1 (corresponded to derivatives 2,2'-bithienyl 5 substituted). 5-(3-buten-1-ynyl) -2, 2 '-bithienyl have been isolated from several plants and it antimicrobial and nematicidal activities [16] have been reported (antimicrobial activity against the plants pathogens: Colletotrichum sp, Fusarium oxysporum, Phomopsis viticola, and Peltula. obscurans [19] or against the human pathogens: Candida albicans, Escherichia coli and Sarcina lutea [20] ). We studied the activity of the pure compound 5-(3-buten-1-ynyl) -2,2'bithienyl against two resistant strains of Streptococcus pneumoniae (ATCC 49619 and 24-CCPN-02) and the MIC value was equal for both strains (Table 3 ). This is the first Essential oil of Chrysactinia mexicana Natural Product Communications Vol. 6 (7) 2011 1037 report of the activity of 5-(3-buten-1-ynyl)-2, 2'-bithienyl on the pathogen causing respiratory tract infectious diseases in humans. The activities found for both, the compound isolated and essential oil were similar, this finding could be explained because the main component in the essential oil is 5-(3-buten-1-ynyl)-2,2'-bithienyl that representing 75% of the total area.
On the other hand, we did an analysis of the essential oil of leaves but the compound 5-(3-buten-1-ynyl)-2, 2'-bithienyl was not detected. Therefore, we decide to prepare again extracts of the leaves, root bark, twigs and bark of the trunk (side closest to the root) using the solvents hexane, methylene chloride and methanol (1:1:1), agree with the report by Domínguez [15] . Our results showed that the compound was not present in the aerial part. The difference in the composition of the oil could be attributed to the date and place of collection.
The antimicrobial activity displayed by Chrysactinia mexicana essential oil against Streptococcus pneumoniae supports the traditional use of this plant for the treatment of infectious diseases. The isolation biodirected afforded the 5-(3-buten-1-ynyl)-2,2'-bithienyl as the principal compound responsible of the antimicrobial activity shown by this plant. The results presented here are important in the search for new antimicrobial agents against bacteria responsible for respiratory diseases, especially those resistant to conventional antibiotics. 
Experimental

Isolation of essential oil:
The essential oil was obtained by hydrodistillation of ground fresh root bark for 4 h, using a Clevenger-type apparatus. Essential oil was conserved at -4C until use.
CG/MS analysis:
Analysis of the essential oil was performed using an Agilent Technologies 6890N gas chromatograph equipped with an HP-5ms column (30 m  0.25 mm i.d., 0.25 m film thickness) and a 5973 INERT selective mass spectrometer. The carrier gas was helium (99.999%) at a flow rate of 0.5 mL/min; ionization energy was 70 eV. Data acquisition was scan mode. Ionization source temperature was 230C, quadrupole temperature was 150C, and the injector temperature was 220C. Oven temperature was programmed to 35C for 9 min, then from 35C to 150C at 3C/min and held for 10 min, then at 10C/min to 250C, and finally at 3C/min to 270C and held for 10 min. The samples were injected using the splitless mode. The injection volume was 2 L. Components were identified by comparison of their retention indices (Kovats indices) relative to C 8 -C 20 n-alkanes, and their mass spectra were compared with mass spectra from the US National Institute of Standards and Technology (NIST) library and reference data [21] . Relative percentages of components were calculated based on GC peak areas without using correction factors.
Isolation of 5-(3-buten-1-ynyl)-2,2'-bithienyl:
Essential oil (17.3 mg) obtained from the Chrysactinia mexicana root bark by hydrodistillation was subjected to inverse phase column chromatography over C-18. Elution was started with MeOH:H 2 O 90:10 to 0.5 mL/min. until the principal compound was eluted and then with MeOH. Finally 6 fractions were obtained (F1 to F6). On the basis of the antimicrobial activity, F5 (5.9 mg) was further fractioned in column chromatography over silica gel with hexane and then with MeOH to give 4 fractions (F5a to F5d). According to its antimicrobial activity, fraction F5b (3.8 mg) was further analyzed by CG/MS, IR, 1 HNMR, 13 C NMR and 2D NMR (COSY, HMQC and HMBC) and identified as 5-(3-buten-1-ynyl)-2, 2'-bithienyl. NMR Spectra were recorder on Bruker Avance DPX 400 equipment.
Antimicrobial activity: Both the oil and the isolated compound were tested for their antimicrobial activity. Streptococcus pneumoniae strains resistant to -lactamic antimicrobials, were tested with microdilution assays according to the National Committee for Clinical Laboratory Standards [22] . In order to prepare the inocula, Streptococcus pneumoniae strains were cultured in Petri dishes containing blood agar (Bacto, Becton Dickinson). Plates were incubated overnight at 37C and suspensions were prepared by transferring colonies to 0.85% NaCl solution until the turbidity of the 0.5 McFarland standard was reached. The suspensions were diluted 1:50 with cation-adjusted Mueller-Hinton broth supplemented with 5% lysed horse blood (CAMHB-LHB; BBL, Becton Dickinson) to make the working suspensions of Streptococcus pneumoniae. The essential oil was prepared at a concentration of 2 mg/mL in 20% of DMSO in CAMHB-LHB. The antimicrobial activity assay was performed in flat-bottom 96-well polystyrene microplates
